Glofitamab Plus Gemcitabine and Oxaliplatin (GemOx) in Relapsed or Refractory Primary and Secondary Central Nervous System Lymphoma

​ Conditions: PCNSL (Primary CNS Lymphoma); Central Nervous System Lymphoma; Secondary Central Nervous System Lymphoma (SCNSL)

Interventions: Drug: Glofitamab; Drug: Gemcitabine; Drug: Oxaliplatin; Radiation: ASCT or whole-brain radiotherapy (WBRT); Drug: Obinutuzumab

Sponsors: The First Affiliated Hospital with Nanjing Medical University

Not yet recruiting Conditions: PCNSL (Primary CNS Lymphoma); Central Nervous System Lymphoma; Secondary Central Nervous System Lymphoma (SCNSL)
Interventions: Drug: Glofitamab; Drug: Gemcitabine; Drug: Oxaliplatin; Radiation: ASCT or whole-brain radiotherapy (WBRT); Drug: Obinutuzumab
Sponsors: The First Affiliated Hospital with Nanjing Medical University
Not yet recruiting